The Rhizen Journey!
Our Journey To Be A Leading Oncology-focused Specialty Company Developing Differentiated Products Through Cutting-edge Science and Strategic Partnerships Started in 2008.
Men and women, committed to better protect you around the world.
To assess the safety and efficacy of our novel pipeline.
Accumulated from dedicated research efforts for the last 12 years.
WE ARE ALL IN TO MAKE IT POSSIBLE
- Progress in-house assets through clinical POC and out-license to global partners for large markets
- In-license differentiated assets for development and commercialization
- Build a pipeline of specialty assets across the oncology and onco-inflammation space